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Abstract
Background: Cancer reversion, converting the phenotypes of a cancer cell into those of a normal cell, has been
sporadically observed throughout history. However, no systematic analysis has been attempted so far.
Results: To investigate this from a systems biological perspective, we have constructed a logical network model of
colorectal tumorigenesis by integrating key regulatory molecules and their interactions from previous experimental
data. We identified molecular targets that can reverse cancerous cellular states to a normal state by systematically
perturbing each molecular activity in the network and evaluating the resulting changes of the attractor landscape
with respect to uncontrolled proliferation, EMT, and stemness. Intriguingly, many of the identified targets were well
in accord with previous studies. We further revealed that the identified targets constitute stable network motifs that
contribute to enhancing the robustness of attractors in cancerous cellular states against diverse regulatory signals.
Conclusions: The proposed framework for systems analysis is applicable to the study of tumorigenesis and
reversion of other types of cancer.
Keywords: Cancer reversion, Logical model, Systemic approach, Colorectal cancer, Reversion target, Attractor
landscape evaluation, Functional network motif, Systems biology
Background
Cancer is one of leading causes of death according to the
World Health Organization since 2000 [1]. The most
common features of cancer are uncontrolled proliferation,
epithelial-mesenchymal transition (EMT), and stemness
[2]. Although these features and their underlying mecha-
nisms were extensively studied, cancer still remains as a
complex disease with no single cure probably due to a lack
of systematic approach. Cancer is evolved from normal
cells which are transformed by a number of genetic muta-
tions accumulated in various signaling pathways during
tumorigenesis [3]. Such alterations often make cancer cells
more robust than normal cells to an external apoptotic
stimulus such as targeted drugs in therapeutic approach.
Apoptosis is the programmed cell death, and triggering it
is the ultimate therapeutic goal for most cancer. However,
tumor-selective apoptosis is not always possible, and it is
more likely to cause side effects to normal cells. Therefore,
there have been increasing demands for an alternative
anti-cancer therapeutic strategy by which the uncontrolled
state of cancer cells could be reversed back to the normal
cellular state while preventing normal cells from undergo-
ing apoptosis [4]. Finding this strategy based on cancer re-
version requires the development of a systemic analysis
for quantitative evaluation of a cancerous state. Through
such an analysis, we could comprehensively characterize
important features of cancer and also identify promising
drug targets for cancer reversion.
Since the first observation of cancer reversion
phenomenon from teratoma into normal cells in 1907
[5], numerous reports have shown that cancer reversion
can occur both in vitro and in vivo [6–8]. For instance,
inhibition of overexpressed PPARγ has been shown to
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trigger differentiation of colorectal cancer which is the
second leading cause of cancer mortality in the United
States [9]. However, previous studies were limited to
present the phenomenon itself without providing a sys-
tematic or mechanistic analysis. To reveal the underlying
mechanism of cancer reversion and to discover specific
targets for the reversion in a systematic way, a simplified
but essential molecular regulatory network model needs
to be constructed [10, 11].
The behavior of a cellular system is caused by compli-
cated interactions of molecules that form a complex mo-
lecular interaction network. The steady states of all the
molecules can be represented by an attractor state of the
network which corresponds to a cellular phenotype [12].
However, indeed, the functional properties and pheno-
types of a cell are mainly determined by the steady states
of specific important molecules, not all the molecules
[13]. Cancer can be understood as a functional disease
triggered by the disturbance of such steady states of
functional molecules by the accumulation of somatic
mutations [14]. The complexity of the molecular inter-
action network implicates the existence of inherent func-
tional redundancy. So, there might exist some control
targets that can drive the cancerous cellular states into
normal-like states although multiple molecules in the
network are already disturbed by the occurrence of mu-
tations during tumorigenesis [15]. In this respect, cancer
reversion might be realizable by converting the steady
state of important molecules to that of a normal cell
through a systems approach [16].
In this study, we have constructed a simplified but es-
sential molecular regulatory network model of a colorec-
tal cancer cell to investigate the underlying mechanism
of cancer reversion. Most previous studies focused on
specific mutations accumulated in various signaling
pathways which were frequently observed with cancer
reversion phenomena in colorectal cancer [17, 18]. We
have manually integrated such information through an
extensive survey of literatures and databases, and identi-
fied essential regulatory interactions between key mole-
cules. We have employed a Boolean network model to
describe the logical relationship of molecular interac-
tions. Then, we have explored the cancer reversion
mechanism by systematically perturbing all of the mo-
lecular components in our network model and evaluat-
ing the resulting changes of the attractor landscape with
respect to uncontrolled proliferation, EMT, and stem-
ness. From this analysis, we have identified a set of
promising control targets for cancer reversion, and some
of them are in accord with previous experimental obser-
vations. Moreover, we have analyzed functional network
motifs that are relevant to the target nodes and their sta-
bility in order to understand the underlying mechanism
of cancer reversion. As a result, we found that cancer
reversion can occur by the alleviating the robustness of
the intracellular gene regulatory network. Therefore, our
study provides new insight into the cancer reversion
mechanism through a systematic way of identifying the
control targets.
Methods
Construction of an essential molecular regulatory
network model of colorectal cancer
To investigate the mechanism of cancer reversion in a
system-level approach, we have constructed a simple but
essential molecular regulatory network (34 nodes and
135 links) of colorectal cancer from Kyoto Encyclopedia
of Genes and Genome (KEGG) database, by integrating
major signaling pathways in colorectal cancer (Fig. 1).
Based on these signaling pathways, we have added three
input nodes (EGF, Wnt and DNA damage) that are
closely related to colorectal cancer. In addition, eight of
marker nodes (Snail, SLUG, MMP, E-cadherin, CyclinE,
CyclinD, p21 and Caspase-3) also have been included in
order to classify biological states of resulting attractors
in the network. These marker nodes have been shown to
be highly associated with uncontrolled proliferation,
EMT, and stemness [19–21]. We also added additional
direct or indirect links based on literature surveys and
protein-protein-interaction (PPI) data inferred from
Genome-scale Integrated Analysis of Gene Networks in
Tissues (GIANT) [22] so that our network model was
Fig. 1 The network model with 34 nodes and 135 edges to explore
colorectal cancer reversion phenomena. Each node represents the
biological molecules such as proteins, mRNAs or transcription factors
while each link represents either activation (red) or inhibition (blue). A
dashed-link represents an interaction between transcription factors and
target genes while a solid-link indicates a protein-protein interaction.
Three input signals are colored in yellow, and eight cell state markers are
in purple. The network can be subdivided into six functional modules in
round squares
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confirmed to fit well with the input-output relationship
from the previous studies. Moreover, the entities of
matrix and vectors in weighted sum logic are tuned with
action mechanisms through literature surveys. All the
literatures referred for constructing the network are
summarized in Additional file 1. The detailed descrip-
tions of constructing the regulatory network model of a
colorectal cancer cell are summarized in Supporting
Text. S1 of Additional file 2.
Network update logic formation based on biological
action mechanisms
After constructing the network, we have implemented
the updated logics of our Boolean network by converting
the Boolean operator’s equation based on biological ac-
tion mechanisms into weighted sum logics (Additional
file 3 and Supporting Text. S2). In weighted sum logic, a
network topology with N-nodes can be defined accord-
ing to an N-by-N connectivity matrix, MC, where each
matrix element (MC)ij represents the connection from
node j to node i. The tendency of each node’s state with-
out any incoming signal can be represented as a value in
the basal level of a column vector, VB ⋅ Mutation profiles
and copy number alterations (CNAs) for individual pa-
tients obtained from the big bang model of Sottoriva et
al., the Human Protein Atlas (HPA) and The Cancer
Genome Atlas (TCGA) databases, were projected by
adjusting the entity of VB ⋅ For each discrete time point
t, the state of each node i, denoted Vi
t, can be either 0 or
1. The input to each node is given by the weighted sum
vector, Ws =MC ⋅V
t +VB ⋅ The next state Vi
t + 1 is then









Wsð Þi > 0
Wsð Þi ¼ 0
Wsð Þi < 0
The connectivity matrix in which basal levels of the
weighted sum logics and mutation profiles for simula-
tion are summarized in Additional file 4. The nodes are
synchronously updated at each time step. We also
attempted to apply the asynchronous update rule and
found that the resulting point attractors and their basins
were conserved in both update rules. Since the overall
basin size of point attractors has reached more than 80%
of all the initial states in our result, we concluded that
the phenotypic features of attractor landscapes from
both update rules were similar. The biological and ana-
lytical validities of synchronous update logic are ex-
plained in Additional file 2: Figures S1. The entities of
the connectivity matrix are translated from the logical
equations of the Boolean operators with our custom
code using Matlab® 2014b, while the entities of basal
column vector are driven from experimental data. The
source codes for mathematical simulations are included
in Additional file 5.
General concepts of simulation analysis on the network
model
For large-scale networks, it is usually difficult to obtain
the whole state transition diagram by a full search be-
cause of the computational limitations. Therefore, in our
network model (N = 34), we estimated the attractor land-
scape by investigating the state transition diagram from
a number of randomly sampled initial states such as
100,000. This initial population was sufficiently large for
reliable reproduction of major attractor states, and thus
the phenotypic scores of attractor landscapes were var-
ied within very small (±2%) deviation from the average
score of 100 repetitions. During the perturbation analysis
and validation of our network model, node perturbations
and mutation profiles were implemented by pinning the
state of the corresponding nodes into either 0 or 1. To
qualitatively evaluate the various input-output relation-
ships of our network, we have employed the proposed
method from Helikar et al. [23]. In this simulation, the
activation ratio of eight marker nodes was measured as
increasing the stochastic activity levels of three input
nodes independently.
Quantitative normal-like score evaluations of attractor
landscapes
To quantify the degree of malignancy of cancer, we have
introduced a scoring system for the attractor landscape
in our network based on the combined state of eight
marker nodes. The scoring system allowed us (i) to
match each of the resulting attractors with functional
proximity to the cancer cell phenotype, (ii) to quantify
the malignancy score of cancerous states, and (iii) to
quantitatively calculate a single “normal-like score” of
the all attractor landscape. An attractor landscape of
network is characterized by attractor states and their
corresponding basins of attraction. By using our scoring
system, each attractor state can be quantified based on
three “cancer proximity scores (CPSs)” (proliferation,
EMT, and stemness) which are determined by the com-
bined activity of eight marker nodes of the correspond-
ing attractor state. Low scoring means “proximate to
cancerous”, whereas high scoring indicates “normal-
like”. We calculated a vector of CPSs for an attractor
landscape (Scps = s ⋅ b/btotal), where s represents a matrix
composed of every individual CPSs of each attractor and
b/btotal represents a vector of the relative basin size of
each attractor. The detailed workflow of the scoring
process for an attractor landscape was shown in Fig. 2.
To obtain the normal-like score of a cancerous state
based on the normal-like scoring system, we have used
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CRISPR/Cas9 experimental data from previous studies
in intestinal stem cells [24]. Jarno et al. compared
niche factors dependency, crypt formation and inva-
siveness of organoids with CRISPR/Cas9-mediated
modification of KRAS, APC, p53 and p21(SMAD4)
genes. Thus, we were able to rank malignancy scores
of each mutation profile by fitting the weights of the
vector of CPSs (SCPS) with real data. As a result, the
higher the value of the normal-like score, the higher
the probability that the network attractors are analo-
gous to their biologically normal state in reality.
Thus, we determined the CPSs of network states in
regard to three types of the hallmark of cancer, and
quantitatively presented the normal-like score by
summing CPSs multiplied by the given weights from
Jarno et al. To simplify the weights into integers, we
have set the weights of proliferation, EMT and stem-
ness as six, four and one, respectively. The mutation
profiles of organoids and their simulation analysis for
normal-like scores are summarized in Fig. 3a.
Node perturbation analysis to identify reversion targets
To identify the cancer reversion targets based on the
normal-like score, we have performed a node perturb-
ation analysis by systematically perturbing the molecular
activity of each node in the network. There are three
types of perturbation: activation, inhibition, and restor-
ation perturbations. An activation or inhibition perturb-
ation fixes the state of that node to 1 or 0, respectively,
while a restoration perturbation restores the basal level
of that node back to the value in normal colon cell. Dur-
ing a single node perturbation analysis, we have obtained
several potent cancer reversion targets in the case of
when the normal-like score of the network landscape
has been increased after perturbation [25]. During a
double nodes perturbation analysis, we have classified
perturbation types into three: synergistic, additive and
antagonistic. For instance, we measure how much the
normal-like score increases after performing single- and
double-node perturbations with node A and B. If the in-
crease of normal-like score during the double-node
Fig. 2 A workflow of quantitative evaluation of attractor landscape. To reveal the effective cancer reversion target, we calculated a normal-like
score for a given attractor landscape. The normal-like score represents the quantitative similarity of an attractor landscape with that of normal cells
in regard to three phenotypic aspects of cancer such as proliferation, EMT, and stemness. Every attractor was scored by adding up the scores of
these three aspects and multiplied by the ratio of basin size of attractors among the entire initial states with the given weights from experimental
data. The probable cancer reversion targets can be identified by systematically perturbing each node in the network and selecting the perturbed
nodes that increase the normal-like score after the perturbation
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perturbation is larger, similar or smaller than the sum of
the normal-like scores from the individually perturbed
nodes A and B, then each incident can be classified as
synergistic, additive or antagonistic, respectively. The
range between increased normal-like scores has been
calculated as 20% in average after performing double
node perturbation in various pairs. Additional explana-
tions are in Additional file 2: Figures S2.
Functional network motif analysis to explore the
reversion mechanisms
Synergistic effects usually arise from emergent properties
of a complex network due to the close interactions of
molecules in the network such as feedback loops or net-
work kernels [26]. Synergistic pairs of cancer reversion
targets strongly interact with each other and constitute
functional network motifs in which every node show a
similar consequence in the normal-like score for the
same node perturbation type. Moreover, fixing a node in
the functional motif may decrease the ability of other
nodes in the motif to increase the normal-like score by
their perturbation. A functional network motif can be
understood as a functional unit block for cancer rever-
sion. If a node in a network motif is mutated, cancer re-
version could not be achievable with any perturbations
among other nodes in the motif. Rather, additional per-
turbation of nodes in the other network motifs could in-
duce cancer reversion [27]. Based on these assumptions,
we have extracted the functional network motifs by the
procedure below. First, we calculated the increase of
normal-like score by perturbing one of the cancer rever-
sion targets, “A”. Second, we systematically fixed any
Fig. 3 The validation of the proposed network through the demonstration of cancer reversion phenomena. a Data-based weight fitting results from
the scoring system. We have ranked the order of malignancy for each mutation profile based on the experimental data (first column on the left). The
three cell state scores for each aspect were obtained from the attractor landscape simulations after projecting each mutation profile to the network
(middle three columns). To fit the cell state score ranks with the experimental data, each cancer proximity score is weighted and summed. As a result,
the colorectal cancer network with the same mutational profile from the experimental data was sorted in similar ranks with the experimental results
(last column on the right). b Various qualitative input-output relationships obtained from the proposed network model. The activation ratio of eight
marker nodes has been measured along with the increase of the three input nodes independently. As a result, the input-output response curves are
well in accord with the previous experimental data. c Clustering the CMSs in the space of cancer proximity scores according to the mutation profile of
each subtype. 12 normal colon cell networks with various expression fold changes (black dots) are well clustered in the upper region of the three-
dimensional space in our scoring system. After the projection of CMS mutation profiles in colored dots, the network models were well clustered
according to the CMS in the three-dimensional space of cancer proximity scores. Moreover, the CMS4 network models (red dots) were predicted to be
in the most malignant state, which agrees with the previous studies [29]. d Cancer reversion phenomena mediated by APC restoration. The reversion
phenomenon was observed in terms of the normal-like score recovery to that of a normal colon cell after the APC restoration of colon cancer cell. The
increase of normal-like score due to the APC restoration (difference of normal-likes scores in last red and blue column on the right) is much higher
than those of APC hyper-activation (difference of normal-likes scores in last red and gray column on the right), KRAS restoration (difference of normal-likes
scores in third and last red column from the left) and p53 restoration (difference of normal-likes scores in second and last red column from the left)
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single node and calculated again the increase of normal-
like score by the node “A”. Third, we selected one fixed
node, “B”, which mostly decreased the normal-like score,
as a member of functional network motif with the node
A. Next, we repeated this process with fixing the node B
in order to find another node, “C”, which mostly decrease
the normal-like score. Finally, we repeated these processes
until the increased normal-like score by the perturbation
of A became smaller enough to neglect. After determining
the entire members of the functional network motif with
this algorithm, we have identified the motifs from the ori-
ginal colorectal cancer regulatory network. After curating
the network, we have tested the stability of each motif by
comparing the averaged node activities over every at-
tractor in colorectal cancer with those of perturbed colo-
rectal cancer (see Additional file 2: Figures S3 for
additional explanations about motif stability analysis).
Robustness analysis of various sequences of mutations
To determine the robustness of the network against exter-
nal perturbations, we examined the number of attractors
and the average basin size of five major attractors. If the
number of attractors is small or the average basin size of
major attractors is large, external perturbation could hardly
change the network state that stays in an attractor state,
which makes the network robust to external perturbations
[28]. During the robustness analysis, the entire attractor
landscapes have been simulated while accumulating the
node state fixation into either 0 or 1. We have investigated
the robustness of a network against the external signals as
mutations were accumulated, by tracking the changes in the
number of attractors and average basin size of attractions
from five major attractors (Additional file 2: Figures S4).
Results
Proposed network model recapitulating the various
cancer reversion phenomena
With our logical network model of colorectal cancer, we
have tested whether it can successfully recapitulate both
the dynamics of colon cancer cell and various cancer re-
version phenomena reported in previous studies [18].
First, using our logical network model, we have simu-
lated the various input-output relationships observed in
normal colon cells under various conditions. Figure 3b
shows that the functional relationships between three in-
put stimuli and eight cell state markers of the network
in the previous studies are reproduced by our network
model, confirming that our network model successfully
implemented the dynamics of normal colon cell [19–21].
Next, we have projected the 12 mutation profiles sets ran-
domly selected from four consensus molecular subtypes
(CMS) of colorectal cancer into our network model to
obtain 48 CMS network models [29]. Guinney et al. have
clustered colorectal cancer into four distinctive subtypes
based on the statistical differences of gene expression data.
From evaluation of the CPSs for each CMS, the network
models were well clustered according to the CMS in the
three-dimensional space of CPSs (Fig. 3c). This result indi-
cates that our network model was successfully trans-
formed into that of a colon cancer cell with the mutation
profiles. Thus, our three-dimensional scoring system is
sufficient to capture phenotypic characteristics of colorec-
tal cancer such as CMS profiles. Moreover, the CMS4 net-
work models were predicted to be on the most malignant
state, which is well in accord with the work of Guinney et
al. [29]. To further test the validity of our network model,
we have simulated the cancer reversion for colorectal can-
cer network models by restoring the basal level of APC.
During the simulation, the mutation profiles were ob-
tained from the patients’ data in Sottoriva et al. [30]. We
observed that the reversion phenomenon was enhanced
most significantly in cancer network with KRAS hyperac-
tivation, APC deletion, and p53 deletion (Fig. 3d) [18]. To-
gether, these results indicate that our network model and
its dynamics effectively demonstrated the biological char-
acteristics of normal colon cell and the cancer reversion
phenomena in colorectal cancer.
Systematic identification of cancer reversion targets by
single node perturbation analysis
Next, we have performed the single node perturbation
analysis to predict the cancer reversion targets (see the
Methods section for detailed explanations of node per-
turbation analysis). The targets were selected such that
the normal-like score of attractors increased for the
three different perturbations of it, activation, inhibition,
or restoration. Every node in the network has been per-
turbed individually and then compared with one an-
other. As a result, we could identify a set of target nodes
(E2F1, ARF, Rb, Akt, KRAS, p21, PP2A, MMP, APC,
BRCA1, and p53), whose alterations can induce cancer
reversion (Fig. 4a). These 11 suggested cancer reversion
targets were further analyzed and verified to be robust
against the structural or dynamical perturbations of the
network (Additional file 2: Figures S5). Moreover, the
statistical significance of these targets were analyzed to
ensure the simulation results (Additional file 6 and
Additional file 2: Figures S6). Among them, E2F1, Akt,
KRAS, p21, PP2A, APC, and p53 have been reported to
influence deeply cancer reversion in the previous studies
(Fig. 4a). For instance, E2F1 is suggested to be a prob-
able target of cancer reversion due to its function to de-
crease the recurrence of colorectal cancer and arrest the
cell cycle [31]. The inhibition of Akt is also known not
only to suppress colon cancer growth in vitro and in
vivo but also to keep the homeostasis of colon tissue for
its functional maintenance [32]. In addition, inhibiting
KRAS mutation has shown to disrupt maintenance of
Kim et al. BMC Systems Biology  (2017) 11:45 Page 6 of 11
cancer in mice [33]. Moreover, p21 has been suggested
to control the cell cycle, and its activation eventually fa-
cilitated the recovery of the functional cell cycle control
system in cancer cell [34]. APC restoration has stimu-
lated cellular differentiation and reestablished crypt
homeostasis in colorectal cancer [18]. Finally, restoring
the loss of function of PP2A has previously shown to
drive the phenotypic reversion of colorectal cancer [35].
Furthermore, our result suggests that other four targets
(ARF, Rb, MMP, and BRCA1) could be potential targets
for cancer reversion, even though they have not been
previously elucidated (Fig. 4a). ARF and Rb, which are
involved in controlling cell cycle, are known to decrease
in expression levels in colorectal cancer and act as
tumor suppressors [36]. MMP is an important marker in
colorectal cancer since it not only regulates invasiveness
but also affects prognosis in patients [37]. Moreover, the
risk of colorectal cancer conferred by mutations in
BRCA1 is recently increasing, implying that BRCA1
might play a key role in colorectal tumorigenesis [38].
Therefore, our results suggest that these four molecules
could be potential targets that can restore cancerous
states to normal state.
Four stable network motifs that critically enhance the
robustness of cancer cell networks
Our single node perturbation simulation has suggested
11 cancer reversion targets. We further analyzed double
nodes perturbation to find the synergistic pairs among
seven targets by applying inhibition or activation perturb-
ation, where restoration perturbation was not considered
due to the complexity of simulation analysis. As a result,
we identified three synergistic pairs (KRAS-Akt, Akt-
PP2A, and PP2A-KRAS) which were selected when an in-
crease in the normal-like score for two node perturbation
is larger than the sum of increases for individual node per-
turbations (Fig. 4b). The synergistic effects observed in
double node perturbation simulation imply the existence
of functional motifs that act as a functional unit block for
cancer reversion. Thus, we have parsed the motif which is
composed of the synergistic pairs among the cancer rever-
sion target nodes. Interestingly, every node in synergistic
pairs is included in the EGF signal transduction pathway.
As a result, the synergistic pairs act together as a func-
tional motif which controls the EGF signal propagation to
the remaining network nodes ranked at the lower level of
hierarchy (Fig. 4c). Our result indicates that perturbing
any multiple nodes in the functional motif could induce
synergistic effects on cancer reversion, which might be an
effective strategy to trigger the cancer reversion with mini-
mum number of control nodes. The double nodes per-
turbation results are summarized in Additional file 6 and
Additional file 2: Figures S7.
After the double nodes perturbation analysis regarding
the mechanistic correlations between seven cancer re-
version targets, we further analyzed functional motifs
that contain these cancer reversion targets (see the
Methods section for detailed explanations of functional
Fig. 4 Probable cancer reversion targets identified from the single node perturbation. a Eleven probable cancer reversion targets with three types
of perturbation, including activation, inhibition, and restoration, are listed (left). Seven of them are listed with the supporting evidence (right). b
Double node perturbation simulation has revealed three synergistic pairs (blue) which were selected when the increase of normal-like score for
two node perturbation is larger than the sum of each increase of normal-like score of single node perturbation. c The functional network motif
related with synergistic pairs. The identified motif is a functional unit of EGF signal transduction which contains EGF and its downstream nodes
Kim et al. BMC Systems Biology  (2017) 11:45 Page 7 of 11
motif analysis). The identified target nodes have consti-
tuted four functional motifs that are highly relevant to
the gene regulatory pathways indicated in Fig. 5a. Fixing
any node of the motifs to either 0 or 1 largely sup-
pressed the increase of normal-like score caused by the
perturbation of cancer reversion targets. In our study,
the identified functional motifs are basic units of cancer
reversion phenomena, which are closely related to cellu-
lar responses of cancer cells to external signals, such as
growth signal response, EMT or cell cycle control sig-
nals. After grouping the predicted cancer reversion tar-
gets in four functional motifs, we have performed motif
stability analysis to confirm the significance of four mo-
tifs. The basic principle for determining the stability of
target nodes in each functional unit is to find a set of
nodes that tend to converge on a specific state, 0 or 1,
regardless of their initial states. The set of average node
activities in four motifs have dramatically changed to the
values of near 0.5 from 0 or 1 after perturbing cancer re-
version targets (Fig. 5b and Additional file 2: Figures S3).
If the functional motif in a cancerous state is robust to
external signals, then the node activities of the motif
would be insensitive to the external signals and thus
converge to 0 or 1. In this regard, the node activities of
near 0.5 after disturbing the cancer reversion targets
means the decrease of the robustness to external pertur-
bations. The perturbation of the predicted cancer rever-
sion targets in our study has shown to decrease the
stability of the functional motifs. Thus, these motifs be-
came sensitive to the external signals, and easily changed
the cell state and functions according to their environ-
mental conditions. Together, our results indicate that
cancer can be characterized as the stable functional
motif that contributes to enhancing the robustness of
cancer-related attractors, suggesting that inhibiting such
a stability of functional motifs could be an efficient strat-
egy for cancer reversion.
The cancer reversion mechanism revealed by perturbing
the stable network motifs
Our motif stability analysis has revealed that the major
difference between colon cancer cells and normal cells is
the stability of functional motifs. Because the stability of
functional motifs represents the responsiveness to the
external signals, cancer cells have the characteristics of
higher state stability than normal cells. This indicates
that the cancer cells become robust against external per-
turbation during tumorigenesis, and thus controlling the
robustness can reverse cancerous state to normal-like
state. The network becomes more robust against exter-
nal signals when the number of attractors decreases or a
basin size of attraction increases. So, we had further ana-
lyzed the changes of robustness during the tumorigen-
esis by tracking the number of attractors and the
average basin size of attraction in each step when muta-
tions were sequentially accumulated (see the Methods
section for detailed explanations of robustness analysis).
The most commonly observed mutation sequence in
colorectal cancer gradually increased the robustness of
the network at each step of mutation accumulation
Fig. 5 Four stable motifs of eleven cancer reversion targets. a All of the four motifs are relevant to the signal transduction pathways that are
closely involved in colorectal cancer progression. b Changes of node activities for APC restoration in each motif. For APC mutation or restoration,
the average expression level of some molecules is robustly fixed to 1 (red) or 0 (blue) regardless of external signals. However, the activities of
some other nodes can fluctuate according to external signals, and thus show 0.5 (purple) on average
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compared to the case of randomly selected mutation
sequences, whereas reversing such a sequence caused
a transient increase of the robustness near the last
step of the sequence (Fig. 6). Moreover, when we
considered randomly selected mutation sequences and
determined each mutation type to decrease the
normal-like score, we also obtained a similar pattern
with the reverse of the most observed mutation se-
quence in colorectal tumorigenesis. Furthermore,
most of the randomly selected mutation sequences
have not shown significant increases of the robustness
as mutations were accumulated. These analyses indi-
cate that the specific mutation sequences accumulated
during colorectal tumorigenesis might be preferen-
tially selected for a cancer cell to avoid sensitive re-
sponses to external signals, and therefore such a
robustness would be a major characteristics of cancer
cells. Thus, perturbation of the stable motifs by alter-
ing the reversion targets may decrease the robustness
of cancer cells against the external signals. Taken to-
gether, our results suggest that the key strategy for
cancer reversion is to increase the responsiveness of
cancer cells to external signals by disturbing stable
functional motifs of cancer cells.
Discussion
The systemic view of cancer biology has been highlighted
for a long time. The hallmarks of cancer have known to be
associated with the complex dynamics of molecular inter-
action networks [39]. A variety of network models of can-
cer cells has been previously established to investigate such
dynamic features of the network from a systems biological
perspective. However, previous studies have mainly focused
on qualitative assessments of cancer such as changes in
input-output relationships in cancer cells or comparison of
major attractors between normal and cancer cells [19, 40].
For instance, a recent study employed a network modeling
approach to identify control targets for anti-cancer treat-
ment by qualitatively examining the changes of basin size
between major attractors, such as proliferation and apop-
tosis [40]. However, these system-based studies still have
fundamental limitations in systematic control for cancer
reversion because there is no quantitative evaluation of
cancer status. In our study, the resulting normal-like score
of a whole attractor landscape is determined by a set of
several functional characteristics related to cancer malig-
nancy and their weights that reflect the malignancy rank of
experimental data. Thus, the normal-like score not only
contains the phenotypic features of the whole attractor
Fig. 6 The robustness analysis of the sequential mutation accumulations. A network is in general expected to be robust against the external signal
when the number of attractors decreases or the average basin size of the five major attractors increases. Thus, the network becomes robust when the
dot moves toward the left or upper part of the coordinate plane. The results of the sequential accumulation of mutations in colorectal cancer
tumorigenesis have revealed that the robustness of the network against the external signals gradually increases in each step of mutation accumulation
(top left). However, reversing the sequence of mutations accumulated in colorectal cancer tumorigenesis caused the increase of the robustness near the
last step of the sequence (top right). Moreover, when we considered randomly selected mutation sequences (n = 30) and determined each mutation
type to decrease the normal-like score, it also caused the increase of the robustness near the last step of the sequences (bottom left). A representative
trajectory of random mutation sequences is shown in the figure. Furthermore, most of the random mutation accumulation sequences have not shown
any significant increase of the robustness along with the accumulations of mutations (bottom right)
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landscape but also quantitatively define the phenotypic ma-
lignancy. Moreover, the previous study based on the at-
tractor ratio analysis has a limit in estimating whether a
specific control will cause improvement or regression of
malignancy due to a lack of quantitative evaluation of at-
tractor landscape. Our scoring system is able to not only
explore the most efficient drug target among multiple tar-
gets but also quantify its efficiency, which allows a system-
atic control for cancer reversion. Furthermore, the
quantitative analysis of attractor landscapes based on the
normal-like scoring system can be utilized for various types
of cancer as well as colorectal cancer in order to identify
effective control targets in a systemic approach. There still
remains a limitation in our study in that the reconstructed
essential regulatory network model is not complete al-
though we have examined the robustness of our result (see
Additional file 2). Hence, it would be a challenging future
study to further expand the network model and validate it
by experiments.
Dysfunctions of cancer cells arise from a series of mu-
tations accumulated during tumorigenesis. The perman-
ent alterations of a molecular interaction network by
these accumulated mutations seem to prevent cancer re-
version by locking cancer cells to the cancerous state.
Although cancer reversion has been studied for decades
and identified key molecules of high importance, it re-
mains difficult to understand how cancer reversion can
be achieved [4]. Current cancer therapies are usually
performed in terms of tumor regression by inducing
apoptosis in cancer cells. However, tumor regression is
often accompanied by unwanted regression of normal
cells, one of the frequent side effects of cancer treat-
ments [41]. To overcome these side effects, we focused
on restoring the functional phenotypes of cancer cells to
those of normal cells rather than tumor regression. To
achieve this, we have set the cell cycle arrest index to be
of greater importance than that of apoptosis in order to
approach cancer reversion without inducing apoptosis in
normal cells. In addition to cell cycle arrest, the attractor
landscape was assessed by EMT and stemness, represen-
tative functional phenotypes of cancerous states, to
quantify the transformation to a normal-like state. Taken
together, we suggest that the reverse control based on
these phenotypes can return cancer cells to functionally
normal cellular states, which can pave the way to new
anti-cancer treatments.
Conclusions
To investigate the underlying mechanism of colorectal
cancer reversion from a systems perspective, we have
constructed a logical network model of colorectal
tumorigenesis by integrating key regulatory molecules
and their interactions from an extensive survey of litera-
ture and experimental data. We established a Boolean
network model and validated its logical rules for every
node in order to create a biologically relevant molecular
regulatory network that can mimic the signaling dynam-
ics and tumorigenesis in a colorectal cell. By systematic-
ally perturbing each of the molecules in the network, we
identified cancer reversion targets that can transform
cancerous cellular states to normal-like states. Moreover,
we quantitatively evaluated the resulting changes of the
attractor landscape through our scoring system with re-
spect to uncontrolled proliferation, EMT, and stemness.
Interestingly, many of the identified molecular targets
were well in agreement with previous studies. We fur-
ther revealed that the identified targets constitute func-
tionally stable network motifs that contribute to
enhancing the robustness of attractors in a cancerous
state against various external regulatory signals. Our
study provides a new approach to understanding colo-
rectal tumorigenesis and offers promising targets that
can drive cancer reversion.
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